Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEER trial
ChiCTR-OPN-16008354Phase 4Not yet recruiting
- Sponsor
- Department of Respiratory and Critical Care Medicine, Southwest Hospital
- Start
- Jun 2016
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of bevacizumab and erlotinib in Non-small cell lung cancer (NS-NSCLC) (2 arms), sponsored by Department of Respiratory and Critical Care Medicine, Southwest Hospital. Primary endpoint: Progression-free survival. Planned start Jun 2016; status: not yet recruiting.
02
Drugs
bevacizumaberlotinib
03
Conditions
Non-small cell lung cancer (NS-NSCLC)
Beyond the preview
Go deeper on ChiCTR-OPN-16008354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-16008354.